Acetadote
Generic name:acetylcysteine injection
Drug class:Antidotes
Approval date: January 23, 2004
Company: Cumberland Pharmaceuticals
Treatment for: Acetaminophen Overdose
FDA approves Acetadote
The U.S. Food and Drug Administration (FDA) has approved Acetadote, an injectable drug used to treat acetaminophen overdose.Acetadote (acetylcysteine) injection will be used in an emergency room setting to prevent or lessen potential liver damage resulting from an overdose of acetaminophen, the leading cause of drug toxicity in the United States. According to the FDA, more than 56,000 emergency room visits and 100 deaths occur each year due to unintentional overdoses of acetaminophen, a common ingredient in many over-the-counter painkillers. Acetadote, administered intravenously within 8 to 10 hours after ingestion of a potentially hepatotoxic quantity of acetaminophen, is indicated to prevent or lessen hepatic injury.
What is Acetadote
Acetadote is the first injectable treatment for acetaminophen overdose available in the United States.
Source: Cumberland Pharmaceuticals
More about Acetadote (acetylcysteine)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Pricing & coupons
- Generic availability
- Drug class: antidotes
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
